Q1 2025 Bioceres Crop Solutions Corp Earnings Call Transcript
Key Points
- Bioceres Crop Solutions Corp (BIOX) reported significant growth in North America and Brazil, with contributions from the Syngenta collaboration expanding 2.5 times as a percent of total gross profit.
- The company's technologies received global recognition, including the prestigious EPA Green Chemistry Award for its bio insecticidal platform.
- Regulatory approvals for HP4 soy cultivation were granted in Uruguay and Bolivia, making it the second most broadly approved soybean GMO event.
- The company is seeing positive momentum in new markets such as Mexico and from recent product launches in Uruguay.
- Gross margin expanded from 38% last year to almost 40%, indicating improved profitability despite revenue challenges.
- Total revenues for the quarter were $93.3 million, a 20% decrease from the previous year, primarily due to a lack of rain in Argentina.
- The Argentine market remains a significant factor in shaping the company's performance, with a substantial shift from corn to soybeans impacting sales.
- The crop nutrition segment saw a significant year-over-year decline, explaining more than half of the top-line decrease.
- The company consciously decided to forego sales with unattractive margins and cash conversion cycles, affecting crop protection sales.
- Financial debt stood at $250 million, with a leverage ratio increase to 2.9 turns, approaching the company's maximum leverage target.
Good morning, ladies and gentlemen. And thank you for standing by. Welcome to the Bioceres Crop Solutions Corp fiscal first quarter, 2025 financial and operational results, Corp, all lines have been placed on mute during the presentation portion of the call with an opportunity for question and answer. At the end. (Operator instructions). I would now like to turn the conference call over to Paula Svante, Head of Investor Relations to begin.
Thank you and good morning to everyone on the call. Welcome to Bioceres Crop Solutions fiscal quarter 2025 1st quarter earnings conference call. Our prepared remarks today will be led by our Chief Executive Officer Federico Trucco and our Chief Financial Officer Enrique Lecube.
Both of them will be available for the Q&A session following the presentation during this call. We will make forward-looking statements. These statements are based on current expectations and assumptions that are subject to various risks and uncertainties. I refer you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
